2025 年基準:了解 IVD 使用者體驗
市場調查報告書
商品編碼
1786120

2025 年基準:了解 IVD 使用者體驗

Benchmarking for 2025: Understanding the IVD User Experience

出版日期: | 出版商: Kalorama Information | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

本報告展示了一項針對臨床診斷專業人員的全面、多年調查(2019、2020、2022 和 2025 年)的結果,重點關注他們與供應商的合作體驗、產品使用情況、購買行為和運營課題。這些調查結果提供了切實可行的見解,以加強客戶參與度、支持產品創新並改善整個 IVD 行業的服務交付。這些見解涵蓋了關鍵的臨床診斷領域,包括臨床化學、分子診斷和微生物學。

本報表包含一個 Tableau 工作簿,可協助您:

  • 揭示並比較領先供應商的單年和多年客戶體驗表現。
  • 探討 2019 年及以後依接觸點劃分的趨勢。
  • 深入了解不同地區、床位規模、細分市場、工作角色和年齡層的顧客滿意度推動因素。

Tableau 工作簿完全互動式,可匯出圖表用於示範、進一步研究或其他需求。這使您能夠對客戶進行基準測試,顯示公司業績,或將其與競爭對手進行比較。如有需要,可提供此工作簿的使用教學課程。

本報告為供應商提供在 IVD 市場中取得優勢所需的洞察。了解客戶體驗有助於供應商加強與現有客戶的關係並建立新客戶。

2025 年版簡要概述了人們對 IVD 供應商的當前看法,並重點關注以下目標:

  • 使臨床診斷供應商能夠在整個客戶購買生命週期內將其客戶體驗與競爭對手進行基準測試。
  • 了解每個供應商在客戶購買生命週期中每個接觸點的相對優勢和劣勢。
  • 確定每個接觸點在顧客購買生命週期中的相對重要性。
  • 評估實驗室目前如何使用人工智慧,以及哪些應用最有益。
  • 評估關稅和人員短缺如何影響實驗室運作。

Kalorama Information and Bioinformatics 設計了一個線上定量調查,以實現這些目標。

  • 本報告共收集了 229 位受訪者。
  • 這項調查是縱向調查,涵蓋了過去六年,並在 2019 年、2020 年、2022 年和 2025 年進行了多次調查。
  • 調查包含 57 個問題(包括人口統計),平均回應時間約 20 分鐘。

目錄

top line報告

  • 摘要
  • 主要發現
  • 人口統計概覽
  • IVD 供應商排名
  • 實驗室在 AI、關稅和人員短缺方面的經驗
  • Tableau 使用者體驗
  • 方法論與人口統計
  • 關於研究公司

Tableau工作簿

  • 1a. 客戶概況
  • 2a. 顧客體驗
  • 3a. 顧客體驗趨勢
  • 4a. 接觸點績效
  • 5a. 象限分析
  • 6a. COVID-19 影響
  • 6b. COVID-19 支持
  • 7a. 職業、年齡和地區
  • 7b.角色與職責
  • 7c. 產品訂購
  • 7d. 已進行的測試
  • 7e. 合規性
  • 7f. 組織類型與規模
  • 7g. GPO
  • 7h. 供應商和已進行的測試
  • 7j. 供應商使用情況與特徵
  • 8a. 概述
  • 8b. 顧客體驗模型
  • 8c. 象限分析
  • 8d. 桑基圖
  • 8e. 關於研究公司

*附註2019-2025 Tableau 工作簿中的大多數儀表板都提供了趨勢圖。

2025年簡介被做的企業

  • Abbott
  • Agilent
  • ALPCO Diagnostics
  • Asuragen
  • AutoGenomics
  • BD Biosciences
  • Beckman Coulter
  • BioFire
  • Bio-Rad
  • Bruker
  • Cepheid
  • DiaSorin
  • EKF Diagnostics
  • ERBA Diagnostics
  • GenMark Diagnostics
  • Illumina
  • Meridian
  • Miltenyi Biotec
  • QuidelOrtho
  • Panasonic
  • Revvity
  • QIAGEN
  • Randox
  • Roche
  • SCIEX
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Tosoh
  • Werfen
簡介目錄
Product Code: 25-039KA

This report presents findings from a comprehensive survey of clinical diagnostics professionals, across multiple years (2019, 2020, 2022, and 2025), focusing on their experiences with vendors, product usage, purchasing behavior, and operational challenges. The findings offer actionable insights to enhance customer engagement, support product innovation, and improve service delivery across the IVD industry. These insights span key areas of clinical diagnostics, including clinical chemistry, molecular diagnostics, and microbiology.

The report includes a Tableau workbook which will allow you to:

  • Uncover and compare single and multi-year customer experience performances for leading vendors.
  • Explore touchpoint-specific trends since 2019.
  • Gain insights into customer satisfaction drivers across different regions, bed sizes, market segments, job positions, and age.

The Tableau workbook is fully interactive, and can be used to export charts for presentations, further research, or other needs. This will allow you to target your benchmarking to your customer, showcase your company's performance, or compare against competitors. Our team can provide tutorials for navigating this workbook upon request.

This report equips vendors with the insights needed to stay ahead in the IVD market. Understanding customer experience enables vendors to cultivate relationships with current customers and build relationships with new ones.

The 2025 edition is a snapshot of current perceptions towards IVD vendors and will focus on the following objectives:

  • Provide clinical diagnostics vendors with the ability to benchmark their customers' experiences against their competitors across the customer purchasing life cycle.
  • Identify the relative strengths and weaknesses of each vendor across touchpoints in the customer purchasing life cycle.
  • Determine the relative importance of each touchpoint in the customer purchasing life cycle.
  • Assess how labs are currently utilizing AI and which applications are most beneficial.
  • Evaluate how tariffs and staffing shortages have impacted lab operations.

Kalorama Information and Bioinformatics designed an online quantitative survey to address these objectives.

  • The survey this report was based on was fielded to n=229 respondents.
  • This study is longitudinal and trends over the course of the last six years, including waves from 2019, 2020, 2022 and 2025.
  • The survey contained 57 questions (including demographics) and took a median time of about 20 minutes to complete.

Table of Contents

Topline Report

  • Overview
  • Topline Findings
  • Demographics Overview
  • IVD Vendor Rankings
  • Laboratory Experiences with AI, Tariffs, and Staffing Shortages
  • Navigating Tableau
  • Methodology and Demographics
  • About Us

Tableau Workbook

  • 1a. Customer Profile
  • 2a. Customer Experience
  • 3a. Customer Experience Trended
  • 4a. Touchpoint Performance
  • 5a. Quadrant Analysis
  • 6a. COVID-19 Impact
  • 6b. COVID-19 Support
  • 7a. Job, Age, Region
  • 7b. Roles & Responsibilities
  • 7c. Ordering Products
  • 7d. Tests Performed
  • 7e. Compliance
  • 7f. Organization Type & Size
  • 7g. GPOs
  • 7h. Vendor and Tests Performed
  • 7j. Vendor Use & Characteristics
  • 8a. Overview
  • 8b. Customer Experience Model
  • 8c. Quadrant Analysis
  • 8d. Sankey Diagram
  • 8e. About Us

*Note: Trending is provided on most dashboards within the Tableau workbook for 2019-2025.

Companies Profiled in 2025

  • Abbott
  • Agilent
  • ALPCO Diagnostics
  • Asuragen
  • AutoGenomics
  • BD Biosciences
  • Beckman Coulter
  • BioFire
  • Bio-Rad
  • Bruker
  • Cepheid
  • DiaSorin
  • EKF Diagnostics
  • ERBA Diagnostics
  • GenMark Diagnostics
  • Illumina
  • Meridian
  • Miltenyi Biotec
  • QuidelOrtho
  • Panasonic
  • Revvity
  • QIAGEN
  • Randox
  • Roche
  • SCIEX
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Tosoh
  • Werfen